Sale!

NPM1 Gene Mutation Quantitative MRD Monitor Test

Original price was: R2,850.Current price is: R1,850.

-35%

Living with leukaemia requires constant vigilance, and our NPM1 Gene Mutation Quantitative MRD Monitor Test provides the precise monitoring you need for peace of mind. This advanced test detects minimal residual disease (MRD) with 99% accuracy, allowing your healthcare team to identify potential relapse months before symptoms appear. For just ZAR 1,850 (regularly ZAR 2,850), you gain access to cutting-edge molecular monitoring that tracks even the smallest amounts of leukaemia cells remaining after treatment. Our specialised testing helps guide treatment decisions, monitor therapy effectiveness, and provide early warning of disease recurrence. With rapid turnaround times and nationwide coverage including Johannesburg, Cape Town, and Durban, we make advanced leukaemia monitoring accessible to all South Africans. Trust Oracle Genomics for reliable, accurate results that empower you and your medical team in your cancer journey.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

NPM1 Gene MRD Monitoring Test | ZAR 1
NPM1 Gene Mutation Quantitative MRD Monitor Test
R2,850 Original price was: R2,850.R1,850Current price is: R1,850.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Leukaemia Journey with Advanced MRD Monitoring

When you’re navigating leukaemia treatment, uncertainty can be overwhelming. Our NPM1 Gene Mutation Quantitative MRD Monitor Test provides the clarity and confidence you need to stay ahead of your condition. This sophisticated test detects microscopic levels of leukaemia cells that standard tests might miss, giving you and your medical team the critical information needed to make informed treatment decisions.

Understanding Your MRD Monitoring Test

Minimal Residual Disease (MRD) refers to the small number of cancer cells that can remain in your body after treatment, even when you’re in remission. Our NPM1 Gene Mutation Quantitative MRD Monitor uses Real-Time PCR technology to detect these elusive cells with exceptional precision. Think of it as having a highly sensitive security system that alerts you to potential threats long before they become visible problems.

The test specifically tracks mutations in the NPM1 gene, which are common in certain types of acute myeloid leukaemia (AML). By quantifying these mutations over time, we can monitor your response to treatment and detect early signs of relapse when they’re most treatable.

Who Should Consider This Essential Monitoring?

This test is particularly valuable for:

  • AML patients with NPM1 mutations currently in remission
  • Individuals undergoing leukaemia treatment who need to monitor response
  • Patients concerned about potential relapse despite feeling well
  • Those wanting the most sensitive monitoring available for peace of mind
  • People whose treatment plans require precise MRD measurement

Many patients tell us the psychological relief from knowing they’re being closely monitored is as valuable as the medical information itself.

Why Early Detection Matters for Your Health

Early detection of leukaemia relapse can significantly improve treatment outcomes. When relapse is caught early:

  • Treatment is more effective with smaller cancer cell populations
  • Options remain broader before resistance develops
  • Quality of life is preserved by preventing full relapse
  • Medical costs are reduced through earlier intervention
  • Peace of mind is restored through proactive monitoring

One patient from Pretoria shared: “Knowing we’re monitoring so closely lets me focus on living my life, not worrying about my leukaemia.”

Understanding Your Results with Confidence

We know waiting for test results can be anxiety-provoking. That’s why we provide clear, comprehensive reports that your haematologist can easily interpret. Your results will show:

  • Quantitative MRD levels measured with precision
  • Trend analysis comparing to previous tests
  • Clinical significance explained in understandable terms
  • Next steps guidance for you and your medical team

Our medical team is always available to help explain your results and answer any questions you might have.

Affordable Advanced Monitoring for South Africans

Test Option Regular Price Special Price Savings
NPM1 Gene MRD Monitor ZAR 2,850 ZAR 1,850 ZAR 1,000

Considering the potential cost of treating full relapse, this monitoring represents exceptional value for your health investment.

Why Thousands of South Africans Trust Oracle Genomics

  • Nationwide Coverage: Accessible testing in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
  • Rapid Turnaround: Samples processed Monday/Thursday by 11am, reports available Wednesday/Saturday
  • Expert Collaboration: Working closely with leading haematologists and oncologists
  • 99% Accuracy: Advanced Real-Time PCR technology ensures reliable results
  • Patient-Focused: Empathetic support throughout your testing journey

Take the Next Step Toward Confident Monitoring

Don’t wait for uncertainty to create anxiety. With our special pricing of ZAR 1,850, advanced leukaemia monitoring has never been more accessible.



Important Preparation: Please ensure you bring the duly filled MRD Requisition form (Form 22) with your historical data. We require 5mL whole blood or bone marrow in a Lavender Top EDTA tube, shipped refrigerated.

“The peace of mind this monitoring provides is priceless. I can focus on living, not worrying.” – Sarah, Cape Town patient